Open Access

Vitamin D deficiency and fatigue: an unusual presentation

SpringerPlus20154:584

https://doi.org/10.1186/s40064-015-1376-x

Received: 24 February 2015

Accepted: 25 September 2015

Published: 7 October 2015

Abstract

Fatigue is a vague but common complaint that is poorly characterized by physicians as well as patients. While fatigue may result from a number of different etiologies, at the present time, a comprehensive approach to each patient with fatigue does not include routine measurement of serum vitamin D levels. A 61-year-old man was evaluated for excessive daytime fatigue. No features characteristic for depression, sleep apnea, or narcolepsy were present. A comprehensive work-up, including thyroid function tests and testosterone levels, did not reveal any abnormalities. However, serum 25-hydroxyvitamin D level was low, at 18.4 ng/mL. Vitamin D supplementation was initiated. At follow-up in 3 and 12 months, the patient reported complete resolution of daytime fatigue, corresponding to an increase in his vitamin D levels. Possible mechanisms for clinical improvement include effects of vitamin D on components of inflammatory cascades, including tumor necrosis factor-alpha and prostaglandin D2, which result in decrease in central nervous system homeostatic sleep pressure. While more research is needed to determine if patients presenting with fatigue should be routinely screened for vitamin D deficiency, clinicians should consider obtaining vitamin D levels in patients with unexplained fatigue, nonspecific musculoskeletal pain, and risk factors for vitamin D deficiency.

Keywords

Vitamin D deficiency Fatigue Excessive daytime sleepiness

Background

Fatigue is a vague but common complaint that is poorly characterized by physicians as well as patients. While fatigue may result from a number of different etiologies, at the present time, a comprehensive approach to each patient with fatigue does not include routine measurement of serum vitamin D levels. Vitamin D refers to a group of fat-soluble secosteroid hormones, and is typically ingested in dietary sources or manufactured in the skin after exposure to sunlight (Holick 2007). Increasing evidence suggests that vitamin D has many roles beyond its classically described effects on calcium homeostasis and bone health (Holick 2007). Research suggests possible associations between suboptimal levels of vitamin D and development of various diseases, including pulmonary disorders (Black and Scragg 2005; Sita-Lumsden et al. 2007; Camargo et al. 2007; Devereux et al. 2007; Litonjua and Weiss 2007) chronic rhinitis (Abuzeid et al. 2012), tonsillar hypertrophy, (Nunn et al. 1986; Reid et al. 2011), metabolic syndrome (Botella-Carretero et al. 2007), type 2 diabetes (Mattila et al. 2007), hypertension (Forman et al. 2007), cancers of the breast, colon, and prostate (Garland et al. 2006), poor stress resilience (Bracha et al. 2004), depression (Berk et al. 2007), and cognitive decline (Przybelski and Binkley 2007). Vitamin D appears to be necessary for skeletal muscle as well and its deficiency has been associated with nonspecific musculoskeletal pain (Plotnikoff and Quigley 2003), chronic pain (Turner et al. 2008), low back pain (Lotfi et al. 2007), and myopathy (Boltan et al. 2007; Goldstein 2007; Prabhala et al. 2000). Some researchers have even suggested a link between vitamin D deficiency and all-cause mortality (Giovannucci 2007).

Vitamin D also has immunomodulatory activities (Holick 2007). Deficiency of vitamin D might be associated with diseases of immune dysregulation, one manifestation of which could be excessive daytime sleepiness (Zitterman and Gummert 2010; Hoeck and Pall 2011). We present a case of daytime fatigue in an otherwise healthy male who was found to be vitamin D deficient.

Case presentation

A 61-year-old Caucasian man presented to primary care office with complaint of fatigue and daytime sleepiness, especially in the afternoons. His symptoms began gradually 2–3 months prior to presentation, insidiously worsening to the point that he began having functional difficulties with his normal tasks at work in the afternoons. He reported napping almost daily after work and even skipping some of his regular exercise sessions due to fatigue. He denied changes in his weight, new familial or occupational stressors, difficulty falling asleep, snoring, apnea, sleep disruptions, nocturnal awakenings, depression, or anxiety. In fact, his review of symptoms was only positive for chest pain that was worse in the afternoon when he felt tired. He reported good sleep hygiene and was able to get his customary 7–8 h of sleep each night. Before the onset of his symptoms, he had worked fulltime and exercised on an almost daily basis, without experiencing any difficulties. His past medical history was only significant for colon cancer, in remission since surgical resection and completion of systemic adjuvant chemotherapy in 2005 (7 years prior to presentation). He did not take any prescription medications and denied use of tobacco products, alcohol, or recreational drugs.

Physical exam revealed a pleasant male in no distress. Vital signs were within normal limits. His body mass index was 28. No significant abnormalities were detected on complete physical exam. Laboratory data, including thyroid stimulating hormone, liver function tests, and renal indices, were normal (Table 1). EKG and stress echocardiogram were normal. In absence of a common etiology explaining patient’s symptoms, serum 25-hydroxy vitamin D level was obtained and found to be low at 18.4 (normal range 30–80 ng/mL). Vitamin D replacement was initiated with ergocholecalciferol 50,000 international units (IU) weekly for 8 weeks, followed by vitamin D 1000 IU daily.
Table 1

Patient’s lab results on presentation

Lab

Value

Reference range

White blood cell

5.2

4.0–10.0 thousands/cu mm

Hemoglobin

13.9

13.0–16.0 g/dL

Sodium

142

136–145 mmol/L

Potassium

4.0

3.3–5.1 mmol/L

CO2

28

22–30 mmol/L

BUN

17

6–20 mg/dL

Creatinine

0.99

0.80–1.20 mg/L

Glucose

92

65–99 mg/dL

AST

14

0–37 U/L

ALT

15

0–41 U/L

Total CPK

128

30–170 U/L

Erythrocyte sedimentation rate

10

0–10 mm/h

Vitamin B12

1031

243–846 pg/mL

TSH

2.96

0.27–4.20 mL U/L

Testosterone free

47

47–244 pg/mL

CEA

2.1

0.0–4.3 ng/mL

Serum 25-hydroxy vitamin D

18.3

>29 ng/mL

Patient reported improvement of his fatigue and daytime sleepiness within 2 weeks of initiation of vitamin D supplementation and complete resolution of his symptoms within 3 months of vitamin D initiation. In follow-up visit in 3 months, he reported being able to perform his previous daily routine without difficulty. In addition to working full-time, he had resumed his exercise routine (3 sessions of resistance training and at least 6 sessions of 30–60 min of cardiovascular training a week) without experiencing any limitations. He denied chest pain or daytime napping. He stated that—aside from initiating vitamin D supplementation—no other circumstances in his life had changed since his initial evaluation: there had been no interval changes in other medications, diet, social activities, caffeine use, stress level, or work. He continues to feel well and remains completely symptom-free to date. His repeat 25-hydroxy vitamin D levels were 27.2 ng/mL after 3 months of vitamin D supplementation and 32.2 ng/mL after 12 months (Table 2).
Table 2

Patient’s serum 25-hydroxy vitamin D levels

Time

Vitamin D level (ng/mL)

Baseline

18.4

3 months

27.2

12 months

32.2

Discussion

The exact mechanism for the improvement in this patient’s fatigue after identification and treatment of vitamin D deficiency is not known. To our knowledge, this is the second reported case of daytime fatigue and sleepiness resolving upon remediation of vitamin D deficiency. McCarty has previously reported a case of excessive daytime sleepiness and musculoskeletal pain in a 28-year-old African American female that improved with replacement of vitamin D (McCarty 2010). This patient underwent an overnight polysomnogram (PSG) before and after vitamin D repletion (McCarty 2010). While a full sleep evaluation before vitamin D repletion revealed the presence of heavy daytime napping and pervasive fatigue, the PSG did not show evidence of sleep disordered breathing or a sleep-related movement disorder (McCarty 2010). Post-replacement PSG did not show a decrease in episodes and duration of wake after sleep onset or an improvement in sleep continuity, but did reveal an interval decrease in stage N3 sleep, suggesting a reduction in homeostatic sleep pressure following vitamin D replacement (McCarty 2010).

McCarty postulated that vitamin D deficiency may contribute to symptoms of sleepiness via components of inflammatory cascades, including known sleep regulating substances (McCarty et al. 2012). For example, there is an inverse relationship between levels of tumor necrosis factor-alpha (TNF-α) and serum 25-hydroxyvitamin D (Fig. 1) (Peterson and Heffernan 2008). TNF-α has been implicated in the sleepiness associated with obstructive sleep apnea (Peterson and Heffernan 2008; Churchill et al. 2008). Vitamin D deficiency has also been associated with upregulation of nuclear factor kappa-B (NFĸB) (Jablonski et al. 2011), which is responsible for the regulation of numerous substances known to exert homeostatic sleep pressure, including prostaglandin D2 (Chen et al. 1999; Krueger et al. 2009). Prostaglandin D2 functions as a physiologic regulator of sleep and affects the central nervous system homeostatic sleep pressure (Fig. 1) (McCarty et al. 2012).
Fig. 1

Proposed relationship between vitamin D and sleep regulation

Interestingly, the only identifiable potential risk factor our patient had for vitamin D deficiency was skin-protective behavior that consisted of sun avoidance and use of SPF protection. Though vitamin D deficiency is commonly understood to be disproportionately represented in underserved populations (Kakarala et al. 2007), patients residing in northern latitudes (Webb et al. 1988), individuals with darker skin tones (Matsuoka et al. 1991, 1995), the elderly (Holick et al. 2005), the obese (Wortsman et al. 2000), and pregnant or lactating women (Lee et al. 2007), its prevalence among the general population is also increasing (Faiz et al. 2007; Zargar et al. 2007). In fact, vitamin D deficiency or insufficiency is estimated to affect over a billion persons worldwide (Holick 2007). Increased awareness of potential dangers of sun exposure, skin-protective behavior, and urbanization of the population are thought to be some of the factors underlying the increase in prevalence of vitamin D deficiency and insufficiency (Holick 2007). It is of note that this patient’s serum parathyroid hormone level was not checked and therefore, normocalcemic primary hyperparathyroidism cannot be ruled out as a contributing factor to his symptoms.

Conclusions

Our case lends support to the one presented by McCarty that vitamin D deficiency might be an unrecognized and easily reversible etiology of fatigue. Although a causal relationship cannot be confirmed by this case alone, the temporal relationship as well as biological plausibility makes this a possibility. While further study is needed to elucidate the possible mechanism for this association, and whether widespread screening for vitamin D deficiency among patients complaining of daytime sleepiness/fatigue is warranted, clinicians should consider obtaining serum vitamin D levels in patients who present with daytime sleepiness/fatigue, nonspecific musculoskeletal pain, and risk factors for vitamin D deficiency.

Declarations

Authors’ contributions

KJ drafted the manuscript. MS revised the manuscript critically for important intellectual content. Both authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Medicine, University of Florida College of Medicine

References

  1. Abuzeid W, Akbar N, Zacharek M (2012) Vitamin D and chronic rhinitis. Curr Opin Allergy Clin Immunol 12:13–17View ArticleGoogle Scholar
  2. Berk M, Sanders KM, Pasco JA et al (2007) Vitamin D deficiency may play a role in depression. Med Hypotheses 69:1316–1319View ArticleGoogle Scholar
  3. Black PN, Scragg R (2005) Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey. Chest 128:3792–3798View ArticleGoogle Scholar
  4. Boltan DD, Lachar W, Khetan A, Bouffard JP, Roberts WC (2007) Fatal and widespread skeletal myopathy confirmed morphologically years after initiation of simvastatin therapy. Am J Cardiol 99:1171–1176View ArticleGoogle Scholar
  5. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vazquez C, Escobar-Morreale HF (2007) Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 26:573–580View ArticleGoogle Scholar
  6. Bracha HS, Ralston TC, Matsukawa JM, Williams AE, Bernstein DM (2004) Diminished stress resilience in institutionalized elderly patients: is hypovitaminosis D a factor? Am J Geriatr Psychiatry 12:544–545View ArticleGoogle Scholar
  7. Camargo CA Jr, Rifas-Shiman SL, Litonjua AA et al (2007) Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr 85:788–795Google Scholar
  8. Chen Z, Gardi J, Kushikata T, Fang J, Krueger JM (1999) Nuclear factor-kappaB-like activity increases in murine cerebral cortex after sleep deprivation. Am J Physiol 276:R1812–R1818Google Scholar
  9. Churchill L, Rector DM, Yasuda K et al (2008) Tumor necrosis factor alpha: activity dependent expression and promotion of cortical column sleep in rats. Neuroscience 156:71–80View ArticleGoogle Scholar
  10. Devereux G, Litonjua AA, Turner SW et al (2007) Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr 85:853–859Google Scholar
  11. Faiz S, Panunti B, Andrews S (2007) The epidemic of vitamin D deficiency. J La State Med Soc 159:17–20 (quiz, 55) Google Scholar
  12. Forman JP, Giovannucci E, Holmes MD et al (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49:1063–1069View ArticleGoogle Scholar
  13. Garland CF, Garland FC, Gorham ED et al (2006) The role of vitamin D in cancer prevention. Am J Public Health 96:252–261View ArticleGoogle Scholar
  14. Giovannucci E (2007) Can vitamin D reduce total mortality? Arch Intern Med 167:1709–1710View ArticleGoogle Scholar
  15. Goldstein MR (2007) Myopathy, statins, and vitamin D deficiency. Am J Cardiol 100:1328View ArticleGoogle Scholar
  16. Hoeck AD, Pall ML (2011) Will vitamin D supplementation ameliorate disease characterized by chronic inflammation and fatigue? Med Hypotheses 76:208–213View ArticleGoogle Scholar
  17. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281View ArticleGoogle Scholar
  18. Holick MF, Siris ES, Binkley N et al (2005) Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215–3224View ArticleGoogle Scholar
  19. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR (2011) 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57:63–69View ArticleGoogle Scholar
  20. Kakarala RR, Chandana SR, Harris SS, Kocharla LP, Dvorin E (2007) Prevalence of vitamin D deficiency in uninsured women. J Gen Intern Med 22:1180–1183View ArticleGoogle Scholar
  21. Krueger JM, Szentirmai E, Kapas L (2009) Biochemistry of sleep function: a paradigm for brain organization of sleep. In: Amlaner CJ, Fuller PM (eds) Basics of sleep guide, 2nd edn. Sleep Research Society, Westchester, pp 69–74Google Scholar
  22. Lee JM, Smith JR, Philipp BL, Chen TC, Mathieu J, Holick MF (2007) Vitamin D deficiency in a healthy group of mothers and newborn infants. Clin Pediatr (Phila) 46:42–44View ArticleGoogle Scholar
  23. Litonjua AA, Weiss ST (2007) Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol 120:1031–1035View ArticleGoogle Scholar
  24. Lotfi A, Abdel-Nasser AM, Hamdy A, Omran AA, El-Rehany MA (2007) Hypovitaminosis D in female patients with chronic low back pain. Clin Rheumatol 26:1895–1901View ArticleGoogle Scholar
  25. Matsuoka LY, Wortsman J, Haddad JG, Kolm P, Hollis BW (1991) Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol 127:536–538View ArticleGoogle Scholar
  26. Matsuoka LY, Wortsman J, Chen TC, Holick MF (1995) Compensation for the interracial variance in the cutaneous synthesis of vitamin D. J Lab Clin Med 126:452–457Google Scholar
  27. Mattila C, Knekt P, Mannisto S et al (2007) Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30:2569–2570View ArticleGoogle Scholar
  28. McCarty DE (2010) Resolution of hypersomnia following identification and treatment of vitamin D deficiency. J Clin Sleep Med 6:605–608Google Scholar
  29. McCarty DE, Reddy A, Keigley Q, Kim PY, Marino AA (2012) Vitamin D, race, and excessive daytime sleepiness. J Clin Sleep Med 8:693–697Google Scholar
  30. Nunn JD, Katz DR, Barker S et al (1986) Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Immunology 59:479–484Google Scholar
  31. Peterson CA, Heffernan ME (2008) Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J Inflamm (Lond) 5:10View ArticleGoogle Scholar
  32. Plotnikoff GA, Quigley JM (2003) Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 78:1463–1470View ArticleGoogle Scholar
  33. Prabhala A, Garg R, Dandona P (2000) Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med 160:1199–1203View ArticleGoogle Scholar
  34. Przybelski RJ, Binkley NC (2007) Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 460:202–205View ArticleGoogle Scholar
  35. Reid D, Morton R, Salkeld L, Bartley J (2011) Vitamin D and tonsil disease-preliminary observations. Int J Pediatr Otorhinolaryngol 75:261–264View ArticleGoogle Scholar
  36. Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn HJ (2007) Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax 62:1003–1007View ArticleGoogle Scholar
  37. Turner MK, Hooten WM, Schmidt JE, Kerkvliet JL, Townsend CO, Bruce BK (2008) Prevalence and clinical correlates of vitamin D inadequacy among patients with chronic pain. Pain Med 9:979–984View ArticleGoogle Scholar
  38. Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67:373–378View ArticleGoogle Scholar
  39. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693Google Scholar
  40. Zargar AH, Ahmad S, Masoodi SR et al (2007) Vitamin D status in apparently healthy adults in Kashmir Valley of Indian subcontinent. Postgrad Med J 83:713–716View ArticleGoogle Scholar
  41. Zitterman A, Gummert JF (2010) Nonclassical vitamin D actions. Nutrients 2:408–425View ArticleGoogle Scholar

Copyright

© Johnson and Sattari. 2015